Home » Newsletters » BioWorld Science

BioWorld Science

July 24, 2015

View Archived Issues

Phase Ib trial set to evaluate tolerogenic dendritic cells for MS and neuromyelitis optica

Encouraging results on S-44858 for the treatment of CNS diseases

Inotek Pharmaceuticals provides update on development strategy for trabodenoson

Chugai updates pipeline progress of second quarter 2015

DiffronC Technology targeting NR2F6 shows potential for the treatment of leukemia

PharmaMar forms license agreement with TTY Biopharm for Aplidin

CEA-Leti and Diabeloop to develop artificial pancreas to improve diabetes treatment

Novel GSM shows promise for the treatment of AD

Brincidofovir reduces mortality in animal model of smallpox

Cara Therapeutics reports data from phase II trial in uremic pruritus

Norgine patents CCR9 antagonists

Purdue Pharma discloses opioid receptor agonists

Merck & Co. develops ROMK channel blockers

Polyphor divulges selective elastase inhibitors

Lifesci Pharmaceuticals reports KLKB1 inhibitors

Model created to investigate the role of butyrylcholinesterase in Alzheimer's disease

Bristol-Myers Squibb describes IRAK-4 inhibitors

EMA accepts for review MAA for grazoprevir/elbasvir in HCV

Sunesis updates regulatory progress for vosaroxin in AML

EMA committee adopts positive scientific opinion for Mosquirix

Inovio and EORTC to conduct phase II trial of INO-3112 in cervical cancer

Janssen files sNDA for reduced-duration treatment with simeprevir in HCV infection

New preclinical study investigates PharmaCyte's treatment in ascites

Baxalta acquires asparaginase portfolio from Sigma-Tau

Amgen submits sNDA for Kyprolis in relapsed multiple myeloma

AstraZeneca forms partnership with inhaler monitoring company Adherium

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...